BioCentury
ARTICLE | Company News

BiPar team reunites at TriAct

September 11, 2009 1:48 AM UTC

TriAct Therapeutics (San Francisco, Calif.) said G. Kirk Raab and John Schembri joined the cancer company as chairman and CFO, respectively. Both formerly served in those respective roles at BiPar Sci...